Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -0.0209M
March 31, 2026 -0.1809M
December 31, 2025 -0.218M
September 30, 2025 -0.2615M
June 30, 2025 -0.3062M
March 31, 2025 -0.2094M
December 31, 2024 -0.2332M
September 30, 2024 -0.1836M
June 30, 2024 -0.7822M
March 31, 2024 -1.31M
December 31, 2023 -1.841M
September 30, 2023 -1.938M
June 30, 2023 -1.379M
Date Value
March 31, 2023 -0.8873M
December 31, 2022 -0.3487M
September 30, 2022 -0.304M
June 30, 2022 -0.3044M
March 31, 2022 -0.3051M
December 31, 2021 -0.2865M
September 30, 2021 -0.2625M
June 30, 2021 -0.1899M
March 31, 2021 -0.1191M
December 31, 2020 -0.112M
September 30, 2020 -0.084M
June 30, 2020 -0.057M
March 31, 2020 -0.028M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Silence Therapeutics Plc 0.0975M
Biodexa Pharmaceuticals Plc -0.1719M
NuCana Plc -0.3717M
Mereo BioPharma Group Plc -1.195M
HemoGenyx Pharmaceuticals Plc -0.6994M